Brief: Nymox Pharmaceutical announces new prostate cancer clinical trial results
20/04/2015 15:00
April 20 (Reuters) - Nymox Pharmaceutical Corp NYMX.O : * Announces new prostate cancer clinical trial results * New results demonstrate statistically significant better outcomes at up to 2.8 years for nx-1207 treated patients versus controls * Says new study also found all instances of surgery or radiation were decreased by 62.7% * Source text for Eikon ID:nGNXVDHRAa * Further company coverage NYMX.O ((Bengaluru Newsroom; +1 646 223 8780))
Recent news on Nymox Pharmaceutical
See all newsBrief: Nymox Says Required To Resubmit Application To DKMA
Brief: Nymox Pharmaceutical Corp Says Terminated Employment Of Christopher R Riley As CFO (June 27)
Brief: Nymox Announces Appointment Of Christopher R. Riley As Chief Financial Officer
Brief: Nymox Appeals Deficiency Letter
U.S. STOCKS ON THE MOVE-Pot stocks, Nymox, Zynerba